For the quarter ending 2026-03-31, CLDX has $511,254K in assets. $55,028K in debts. $35,729K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 35,729 | 28,871 | 36,037 | 23,044 |
| Maturing in one year or less-USTreasury And Government | 130,939 | 151,749 | 154,098 | - |
| Maturing after one year through three years-USTreasury And Government | 37,550 | 42,485 | 54,939 | - |
| Maturing in one year or less-Corporate Debt Securities | 205,519 | 257,437 | 305,897 | - |
| Maturing after one year through three years-Corporate Debt Securities | 41,721 | 38,031 | 32,252 | - |
| Marketable securities | 415,729 | 489,702 | 547,186 | 607,293 |
| Accounts and other receivables | 230 | 2,015 | 90 | 90 |
| Prepaid and other current assets | 7,534 | 14,076 | 21,026 | 17,977 |
| Total current assets | 459,222 | 534,664 | 604,339 | 648,404 |
| Property and equipment, net | 7,396 | 5,334 | 4,829 | 4,392 |
| Operating lease right-of-use assets, net | 2,012 | 2,437 | 2,717 | 3,121 |
| Intangible assets | 27,190 | 27,190 | 27,190 | 27,190 |
| Other assets | 15,434 | 13,358 | 9,364 | 9,300 |
| Total assets | 511,254 | 582,983 | 648,439 | 692,407 |
| Accounts payable | 10,359 | 1,180 | 4,267 | 2,073 |
| Accrued expenses | 38,418 | 47,029 | 39,715 | 28,424 |
| Current portion of operating lease liabilities | 1,465 | 1,552 | 1,553 | 1,536 |
| Current portion of other long-term liabilities | 1,230 | 1,230 | 930 | 930 |
| Total current liabilities | 51,472 | 50,991 | 46,465 | 32,963 |
| Long-term portion of operating lease liabilities | 443 | 784 | 1,068 | 1,495 |
| Other long-term liabilities | 3,113 | 4,043 | 2,543 | 2,543 |
| Convertible preferred stock, .01 par value 3,000,000 shares authorized no shares issued and outstanding at june 30, 2025 and december 31, 2024 | - | - | - | 0 |
| Total liabilities | 55,028 | 55,818 | 50,076 | 37,001 |
| Common stock, .001 par value 297,000,000 shares authorized 66,568,971 and 66,549,442 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 67 | 67 | 66 | 66 |
| Additional paid-in capital | 2,346,303 | 2,337,453 | 2,327,196 | 2,317,621 |
| Accumulated other comprehensive income | 2,522 | 3,626 | 3,765 | 3,339 |
| Accumulated deficit | -1,892,666 | -1,813,981 | -1,732,664 | -1,665,620 |
| Total stockholders' equity | 456,226 | 527,165 | 598,363 | 655,406 |
| Total liabilities and stockholders' equity | 511,254 | 582,983 | 648,439 | 692,407 |
Celldex Therapeutics, Inc. (CLDX)
Celldex Therapeutics, Inc. (CLDX)